Thank you for sharing!

Your article was successfully shared with the contacts you provided.
The Takeda Pharmaceutical Co. logo is displayed atop the company’s global headquarters in Tokyo. Photo: Kiyoshi Ota/Bloomberg

Attorneys with Keker, Van Nest & Peters are entitled to more than $19 million in disputed fees for their contingent representation of former shareholders, Vice Chancellor Kathaleen McCormick has ruled.

Those fees are included in an over $80 million judgment leveled against Shire U.S. Holdings Inc. in a case that took the uncommon path of going to trial while plaintiffs were represented on contingency.

This premium content is locked for
Delaware Business Court Insider subscribers only.

Already have an account?
Interested in customizing your subscription with Law.com access?
Contact our Sales Professionals at 1-855-808-4530 or send an email
to [email protected] to learn more.

Ellen Bardash

Reprints & Licensing
Mentioned in a Law.com story?

License our industry-leading legal content to extend your thought leadership and build your brand.


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.